Clinical trials in Poland
11,766 studies list at least one site in Poland. 1,773 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Poland recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Hoffmann-La Roche (437) · AstraZeneca (432) · Pfizer (370) · Novartis Pharmaceuticals (344) · Medical University of Warsaw (301) · GlaxoSmithKline (286) · Eli Lilly and Company (270) · Janssen Research & Development, LLC (260)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting28
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum DisorderNov 10, 2026NCT07285798
- Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyNov 10, 2026NCT07602036
- Effects of Tart Cherry and Aronia Extract Supplementation on Selected Physiological Parameters in Endurance-Trained MenNov 10, 2026NCT07885098
- Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects With Reduced Ejection FractionNov 6, 2026NCT07403058
- SIRI Levels Following PENG Block in Pediatric Hip SurgeryNov 6, 2026NCT07607535
Show 23 moreShow fewer
- Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV DiseaseNov 6, 2026NCT07839871
- Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical StudyNov 5, 2026NCT06333405
- Comparison of Spinal Anesthesia With Intrathecal Morphine Versus PENG Block With or Without Dexamethasone in Hip ArthroplastyNov 5, 2026NCT07584200
- Lumbar Paravertebral Block vs Erector Spinae Plane Block in Elderly Patients Undergoing Lumbar Spine SurgeryNov 5, 2026NCT07607509
- ACB and iPACK Blocks With Intravenous Dexamethasone and Perineural Dexmedetomidine in Total Knee ArthroplastyNov 5, 2026NCT07677215
- Intravenous Dexmedetomidine as a Perioperative Autonomic-Immune NeuromodulatorNov 5, 2026NCT07743853
- A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental VitiligoNov 2, 2026NCT07667569
- Vsling™ III: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart FailureOct 28, 2026NCT06002386
- A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia AOct 28, 2026NCT07830732
- Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)Oct 27, 2026NCT06295731
- Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot Syndrome.Oct 26, 2026NCT06843122
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
- Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid CancerOct 21, 2026NCT05468554
- A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Oct 21, 2026NCT07735637
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLOct 20, 2026NCT07297914
- A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramOct 20, 2026NCT07429942
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeOct 19, 2026NCT07344779
- A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyOct 15, 2026NCT06321302
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionOct 13, 2026NCT07128199
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)Oct 13, 2026NCT07817875
- A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)Oct 13, 2026NCT07843940
First site in Poland38
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisNov 10, 2026NCT06429176
- KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)Nov 10, 2026NCT07252739
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingNov 10, 2026NCT07587242
- An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HSNov 9, 2026NCT07665437
- A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisNov 6, 2026NCT07465289
Show 33 moreShow fewer
- Study to Learn About a Respiratory Syncytial Virus Vaccine in Children at High Risk of RSV DiseaseNov 6, 2026NCT07839871
- Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced Epithelial Ovarian CancerNov 6, 2026NCT07851025
- FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and PatientsNov 5, 2026NCT06564389
- A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)Nov 3, 2026NCT05912517
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerNov 3, 2026NCT07409272
- A Study to Learn How Safe ACT-777991 is and How Well it Works in Adults With Non-segmental VitiligoNov 2, 2026NCT07667569
- A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaOct 30, 2026NCT07284758
- Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersOct 29, 2026NCT05098132
- Vsling™ III: Clinical Evaluation of the Vsling™ Device for Ventricular Repair in Patients With Heart FailureOct 28, 2026NCT06002386
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisOct 27, 2026NCT07463521
- Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot Syndrome.Oct 26, 2026NCT06843122
- MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)Oct 26, 2026NCT07431827
- Study of Zodasiran in Adolescent Participants With Homozygous Familial HypercholesterolemiaOct 26, 2026NCT07473843
- Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and AdolescentsOct 26, 2026NCT07660198
- Effect of Exoskeleton-Assisted Walking on Gait Parameters in Healthy AdultsOct 23, 2026NCT07499063
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaOct 23, 2026NCT07562152
- A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)Oct 23, 2026NCT07585266
- A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-studyOct 22, 2026NCT06594393
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaOct 22, 2026NCT06769698
- Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Oct 22, 2026NCT07162883
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseOct 22, 2026NCT07363694
- A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)Oct 21, 2026NCT07393282
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Oct 20, 2026NCT07365319
- A Study of MB-001 in Moderately to Severely Active Ulcerative ColitisOct 20, 2026NCT07374471
- A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramOct 20, 2026NCT07429942
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesOct 20, 2026NCT07672769
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerOct 16, 2026NCT07365995
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisOct 15, 2026NCT07071519
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
- Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).Oct 13, 2026NCT06641414
- An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal PolypsOct 13, 2026NCT07424144
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)Oct 13, 2026NCT07541170
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityOct 13, 2026NCT07595549
Results posted34
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaNov 10, 2026NCT01987492
- Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaNov 9, 2026NCT04091126
- A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung CancerNov 9, 2026NCT04294810
- A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382Nov 6, 2026NCT06032546
- A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)Nov 5, 2026NCT04968912
Show 29 moreShow fewer
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)Nov 5, 2026NCT05620836
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
- Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisNov 3, 2026NCT06058156
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)Nov 2, 2026NCT04502030
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Oct 30, 2026NCT04861259
- KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)Oct 29, 2026NCT04165083
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaOct 29, 2026NCT06341712
- A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyOct 28, 2026NCT02875548
- Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic MigraineOct 28, 2026NCT03832998
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisOct 28, 2026NCT05297448
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- EAGLE Trial CADDIE Artificial Intelligence EndoscopyOct 26, 2026NCT05730192
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)Oct 22, 2026NCT03036488
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsOct 22, 2026NCT04420884
- Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLOct 21, 2026NCT04404283
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)Oct 20, 2026NCT04630028
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminOct 16, 2026NCT06192108
- Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)Oct 15, 2026NCT04701983
- A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerOct 14, 2026NCT05337137
- A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic SyndromeOct 14, 2026NCT05627557
Stopped9
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNov 10, 2026NCT01987492
- Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)TerminatedNov 3, 2026NCT06617429
- Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNTerminatedNov 2, 2026NCT06209736
- A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical StudyTerminatedOct 28, 2026NCT02875548
- Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.TerminatedOct 23, 2026NCT05353413
Show 4 moreShow fewer
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedOct 21, 2026NCT06867094
- Safety and Efficacy Study of PF-06835375 in Primary Immune ThrombocytopeniaTerminatedOct 16, 2026NCT05070845
- Obinutuzumab Versus Rituximab for Acute Lymphoblastic Leukemia/PALG ALL7 "OVERALL"TerminatedOct 15, 2026NCT04920968
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedOct 13, 2026NCT06637631
Newly registered47
- A Study of Brenipatide in Participants With Major Depressive DisorderNov 10, 2026NCT07928245
- A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigNov 10, 2026NCT07929051
- Computer-Assisted Segmentation of Craniofacial Structures and Osteotomy Planning Using CBCT and CTNov 10, 2026NCT07929532
- Intravenous Dexamethasone for PENG Block Analgesia in Children Undergoing Hip SurgeryNov 9, 2026NCT07924670
- Functional Recovery After PENG Block Plus Periarticular Injection Versus Periarticular Injection Alone in Total Hip ArthroplastyNov 9, 2026NCT07924709
Show 42 moreShow fewer
- Use of Transcutaneous Electrical Nerve Stimulation (TENS) in the Treatment of Pain Syndromes in Patients With Lower Limb IschemiaNov 9, 2026NCT07925060
- First Pass Spectral Perfusion From Photon Counting CTNov 9, 2026NCT07925151
- Autonomic and Immune Effects of Regional Anesthesia in Total Hip ArthroplastyNov 9, 2026NCT07925658
- Effects of Different High-Intensity Interval Training Protocols on Physiological and Skeletal Muscle Adaptations in Healthy Young MenNov 9, 2026NCT07926451
- A Study of Bimagrumab in Participants With HFpEFNov 6, 2026NCT07920887
- The Prevalence of Chronic Pain Following Cryoanalgesia and the Nuss Procedure.Nov 6, 2026NCT07923500
- Remote Rehabilitation in Patients With HFpEF (PATRON-HF)Nov 5, 2026NCT07918209
- Continuous Glucose Monitoring Systems in People With Type 2 Diabetes Not Treated With InsulinNov 5, 2026NCT07919236
- A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNov 5, 2026NCT07919405
- Bronchial Hyperresponsiveness in SarcoidosisNov 5, 2026NCT07919665
- The Influence of Hydration on the Viscoelastic Properties of Soft Tissues, Pain and Mobility of PatientsNov 4, 2026NCT07915167
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- WSACS 2026 Delphi Consensus on the Practical Management of Intra-abdominal Hypertension and Abdominal Compartment SyndromeNov 4, 2026NCT07915362
- Indocyanine Green Lymphatic Mapping in Minimally Invasive Sigmoid and Rectal Cancer SurgeryNov 4, 2026NCT07916532
- Asprosin and miRNA Expression in Young Women With Metabolic SyndromeNov 4, 2026NCT07917364
- The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without DiabetesNov 3, 2026NCT07913685
- Return to Physical Activity After Retropublic Transvaginal Sling and Laparoscopic SacrocolpopexyNov 3, 2026NCT07913815
- Comparing Radiotherapy Dose Strategies for Symptom Relief in Large Solid TumorsNov 2, 2026NCT07908914
- Study Evaluating the Safety and Efficacy of the TMChM Prosthesis in the Treatment of People With Chronic Flexor Tendon Fingers InjuriesNov 2, 2026NCT07910123
- Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)Oct 30, 2026NCT07908108
- Multicenter Study for External Validation of the TB-NET ScoreOct 29, 2026NCT07903532
- PRP Versus Saline Hydrodissection for CTS RCTOct 29, 2026NCT07904650
- Fresh Versus Vitrified-Warmed Donor Oocytes: Embryological and Clinical OutcomesOct 29, 2026NCT07904936
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Mi2000 TICI Follow-upOct 28, 2026NCT07902414
- The Role of Simulation Fidelity in Early Surgical Skills EducationOct 27, 2026NCT07899684
- Back Massage Before a Cognitive Task in Healthy Young AdultsOct 26, 2026NCT07893886
- Intravenous Dexamethasone for ESP Block Analgesia in Children Undergoing Idiopathic Scoliosis SurgeryOct 22, 2026NCT07890220
- Effects of Tart Cherry and Aronia Extract Supplementation on Selected Physiological Parameters in Endurance-Trained MenOct 21, 2026NCT07885098
- Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaOct 21, 2026NCT07885891
- Adapting the Sensory Environment to Reduce Stress in Children With Autism During Dental VisitsOct 21, 2026NCT07887243
- Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic LesionsOct 20, 2026NCT07883798
- RBD1119 in Coronary Artery Disease (CAD)Oct 20, 2026NCT07884136
- Home-Based Exercise Program for Diastasis Recti in Early Postpartum WomenOct 20, 2026NCT07884266
- Predicting Declines in Attention and Memory During a Prolonged Mental TaskOct 16, 2026NCT07877389
- A Study of BMS-986553 in Participants With Refractory Autoimmune DiseasesOct 14, 2026NCT07873931
- Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasEOct 14, 2026NCT07874139
- Controlled Study, Performed to Evaluate the Safety and Efficacy of EscharEx and Its Placebo (Gel Vehicle) Compared to Non-surgical Standard of Care in Participants With Venous Leg Ulcers (VLU)Oct 13, 2026NCT06690177
- Vortosiran in Atrial FibrillationOct 13, 2026NCT07870889
- Desarda Repair for Inguinal Hernia in Adolescent MalesOct 13, 2026NCT07870902
- A Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)Oct 13, 2026NCT07871214
- Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to RelapseOct 13, 2026NCT07871864
Studies
Recruiting first, then most recently updated. Showing 50 of 11,766 — search for more.
- A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)Enrolling by invitationNCT06431893Phase 3
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)Enrolling by invitationNCT07161700Phase 2
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With AsthmaRecruitingNCT05222529Phase 2
- A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigNot yet recruitingNCT07929051Phase 3
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingNCT05776927Phase 3
- A Study of Brenipatide in Participants With Major Depressive DisorderNot yet recruitingNCT07928245Phase 2
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Computer-Assisted Segmentation of Craniofacial Structures and Osteotomy Planning Using CBCT and CTNot yet recruitingNCT07929532
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisRecruitingNCT06429176Phase 2
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)RecruitingNCT06345729Phase 3
- A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaRecruitingNCT06023589Phase 3
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingNCT06651281Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)RecruitingNCT06717347Phase 3
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)RecruitingNCT06818643Phase 1/2
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)RecruitingNCT06079671Phase 3
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
- Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyRecruitingNCT07602036Not applicable
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum DisorderRecruitingNCT07285798Phase 3
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyRecruitingNCT07285213Phase 2
- A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruitingNCT07540221Phase 3
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)RecruitingNCT07065240Phase 2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingNCT07555938Phase 3
- A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruitingNCT07430306Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3
- A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)RecruitingNCT07634471Phase 2/3
- A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)RecruitingNCT07159841Phase 2/3
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]RecruitingNCT07099898Phase 3
- A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)RecruitingNCT07366034Phase 3
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3
- A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)RecruitingNCT07519772Phase 1/2
- KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)RecruitingNCT07252739Phase 2
- A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaRecruitingNCT07144163Phase 3
- Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPRecruitingNCT07354074Phase 2
- A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)RecruitingNCT07554339Phase 3